Page last updated: 2024-11-13

deoxyfusapyrone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

deoxyfusapyrone: isolated from Fusarium semitectum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54684866
CHEMBL ID593901
MeSH IDM0233983

Synonyms (10)

Synonym
CHEMBL593901
deoxyneofusapyrone
deoxyfusapyrone
156856-32-5
3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4e,6e,9z)-3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl]pyran-2-one
rel-3-((2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-2-hydroxy-6-((4e,6e,9z)-3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl)-4h-pyran-4-one
3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-hydroxy-6-[(4e,6e,9z)-3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl]pyran-4-one
HY-N10273
CS-0372134
AKOS040756228
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1103189Antifungal activity against Rhodotorula glutinis assessed as growth inhibition at 50 ug/ml after 24 to 72 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103190Antifungal activity against Meyerozyma guilliermondii assessed as growth inhibition at 50 ug/ml after 24 to 72 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID453159Cytotoxicity against human HepG2 cells2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Novel neofusapyrones isolated from Verticillium dahliae as potent antifungal substances.
AID1103192Antifungal activity against Penicillium brevicompactum Dierckx ITEM-449 after 72 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103196Antifungal activity against Aspergillus parasiticus Speare ITEM-11 after 48 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103198Antifungal activity against Botryotinia fuckeliana ITEM-966 after 72 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID453156Antifungal activity against Cochliobolus miyabeanus at 100 ng/ml2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Novel neofusapyrones isolated from Verticillium dahliae as potent antifungal substances.
AID453158Cytotoxicity against human HeLa cells2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Novel neofusapyrones isolated from Verticillium dahliae as potent antifungal substances.
AID1103193Antifungal activity against Penicillium brevicompactum Dierckx ITEM-449 after 48 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103199Antifungal activity against Botryotinia fuckeliana ITEM-966 after 48 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103191Toxicity against Artemia salina (brine shrimp) larvae after 24 hr2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID453157Antibacterial activity against methicillin-resistant Staphylococcus aureus Isolate 87-7927 at 10 ug2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Novel neofusapyrones isolated from Verticillium dahliae as potent antifungal substances.
AID1103197Antifungal activity against Aspergillus parasiticus Speare ITEM-11 after 24 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103200Antifungal activity against Botryotinia fuckeliana ITEM-966 after 24 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103194Antifungal activity against Penicillium brevicompactum Dierckx ITEM-449 after 24 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
AID1103195Antifungal activity against Aspergillus parasiticus Speare ITEM-11 after 72 hr by broth dilution method2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Structure-activity relationships of derivatives of fusapyrone, an antifungal metabolite of Fusarium semitectum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]